Skip to main content
Premium Trial:

Request an Annual Quote

SpeeDx Signs UK, Ireland Distribution Deal

NEW YORK (GenomeWeb) – Australian diagnostics firm SpeeDx announced today that it has signed a distribution deal for its molecular diagnostics in the UK and Ireland with Serosep.

Under the terms of the deal, Serosep will offer SpeeDx's line of multiplexed PlexPCR and ResistancePlus tests throughout the territories. Additional terms were not disclosed.

Last year, SpeeDx — which recently opened a US subsidiary — received CE-IVD marking for its PlexPCR VHS test for VZV, herpes, and syphilis. It also offers the ResistancePlus MG assay for Mycoplasma genitalium. In September, SpeeDx signed a distribution deal for its products covering Scandinavia with Diagen.

The Scan

Billion-Dollar Diversity Initiative

The Howard Hughes Medical Institute is now accepting applications for its new $1.5 billion initiative to boost the diversity of the scientific workforce.

Biotech Co-Founder Arrested

A co-founder of a Los Angeles-based biotech company has been arrested in connection with a murder-for-hire scheme, according to Endpoint News.

Return of the Tasmanian Tiger

The Washington Post reports that a team in Australia is working to bring the thylacine back from extinction.

Nature Papers on Genome of Individual From Pompeii, CircRNA Study Best Practices, More

In Nature this week: first sequenced genome of a person from Pompeii, best practice guidelines for circRNA studies, and more.